Using Human Genetics to Identify Novel Targets for NAFLD/NASH: Opportunities & Challenges

Time: 3:00 pm
day: Day One


• Hearing how human genetics have shown promise in identifying potential therapeutics for many diseases.
• Utilizing large human genetics resources for NAFLD/NASH and understanding how these have been challenging to collect and assemble.
• Exploring why surrogate phenotype data, such as liver fat or liver enzymes may also be good sources of data for target identification